Close Menu

In Nature this week, a team led by researchers at St. Jude Children's Research Hospital report a novel therapy for retinoblastoma. The team performed genomic and epigenetic analyses of retinoblastoma samples, and found that the cancer's genome is stable, though several of its pathways can be deregulated. As the team reports, the only known cancer gene mutated in these tumors is RB1, and that the overall mutational rate is very low.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.